Navigation Links
REACH Registry Demonstrates That Multiple Arterial Disease,Locations Sharply Increase the Risk of Major CV Events in,Outpatients With Atherothrombosis

- The Reduction of Atherothrombosis for Continued Health (REACH)

- Registry 1-Year Results

PARIS, March 20, 2007 /PRNewswire/ --The REACH Registry 1-year results paper published today in the Journal of the American Medical Association (JAMA) show that outpatients with atherothrombosis have a surprisingly high risk of death or major cardiovascular illness, especially if more than one vascular bed is diseased. REACH also documented high event rates that accrued almost linearly over time - in contrast to the sharp rise followed by a leveling off of event rates that is usually seen in patients discharged from hospital after acute events. REACH is the first international outpatient registry to characterize the real-world burden of atherothrombotic disease worldwide (REACH).

- Within a year, around one in seven patients will die, experience a heart attack or stroke, or be hospitalized from a complication arising from atherothrombosis - clogged arteries in the heart, brain or legs.

- Patients with atherothrombosis in the legs (peripheral arterial disease: PAD) have a one in five (21%) chance of dying, having a heart attack or stroke or being hospitalized due to cardiovascular reasons within one year.

- Over the same period of time, for patients who have atherothrombosis in more than one area (heart, brain and/or legs) this risk doubles.

- The risk increases dependent on the number of arterial beds affected; with 5% event rate for patients with risk factors only; 13% for patients with risk factors and one diseased vascular bed, 22% for patients with risk factors and two diseased vascular beds and 26% for patients with risk factors and three diseased vascular beds

- REACH demonstrates that up to 1.75 million CV events could be seen in those patients with multiple arterial disease in the US alone over the next 12 months(X)

For patients without a history of coronary,
'"/>




Page: 1 2 3 4

Related medicine technology :

1. ARRIVE Registry Analysis Identifies Predictors of Stent Thrombosis in Real-World Use of Drug-Eluting Stents
2. Two-Year Patient Registry Results Support Safety and Efficacy of Cypher Sirolimus-Eluting Coronary Stent in Real World Uses
3. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
4. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
5. New Research Demonstrates Broad Efficacy of Azixa (MPC-6827) Against Multiple Tumor Types and in Drug Resistant Cell Lines
6. Algeta Demonstrates Targeted Cancer-killing Potential of Novel Alpha Particle Linked Antibodies in Leading Medical Journal Blood
7. Gerons Telomerase Inhibitor Cancer Drug Demonstrates Good Pharmacokinetics and Tolerability in Phase I/II Trial
8. Frova Phase III Study Data Demonstrates That Short-Term Prevention Treatment Reduces Frequency and Severity of Menstrual Migraine
9. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
10. Newly Published Data Demonstrates Superiority of Cipralex Over Duloxetine for Acute Treatment of Depression
11. Introgens Advexin Demonstrates Clinical Benefit in Inherited Cancer
Post Your Comments:
(Date:9/30/2014)... 2014 MiMedx Group, Inc. (NASDAQ: ... amniotic tissue and patent-protected processes to develop and market ... Orthopedic, Spinal, Sports Medicine, Ophthalmic and Dental sectors of ... Chief Scientific Officer, will present at the Stem Cell ... Tuesday, October 7, 2014, at 5:00PM Pacific Daylight Time. ...
(Date:9/30/2014)... , Sept. 30, 2014 This ... for molecular imaging informatics solutions including nuclear imaging ... and comparison. The study assesses the size of ... 2010 and 2013, and projects future growth based ... as the dynamics taking place in the broader ...
(Date:9/30/2014)... , Sept. 30, 2014 Arbor Pharmaceuticals, ... Summary Global Markets Direct,s, ,Arbor Pharmaceuticals, LLC. ... overview of the Arbor Pharmaceuticals, LLC.,s pharmaceutical research ... information on the current therapeutic developmental pipeline of ... various stages, therapeutics assessment by drug target, mechanism ...
Breaking Medicine Technology:MiMedx to Present at the Stem Cell Meeting on the Mesa 2Analysis of the US Molecular Imaging Informatics Market 2Analysis of the US Molecular Imaging Informatics Market 3Arbor Pharmaceuticals, LLC. - Product Pipeline Review - 2014 2Arbor Pharmaceuticals, LLC. - Product Pipeline Review - 2014 3
... 4, 2011 Reportlinker.com announces that ... available in its catalogue: ... Devices 2011 (Infusion Pumps, Needleless Connectors, ... http://www.reportlinker.com/p0590033/US-Market-for-Infusion-Therapy-Devices-2011-Infusion-Pumps-Needleless-Connectors-IV-Sets.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Equipment_and_Supply In 2010, ...
... Mich., Aug. 3, 2011 Robertson Global Health ... Pty Ltd have announced today that they have signed ... and strategic services company that specializes in health risk ... understanding to deliver RHealth Advisor mobile web as an ...
Cached Medicine Technology:U.S. Market for Infusion Therapy Devices 2011 (Infusion Pumps, Needleless Connectors, IV Sets) 2U.S. Market for Infusion Therapy Devices 2011 (Infusion Pumps, Needleless Connectors, IV Sets) 3U.S. Market for Infusion Therapy Devices 2011 (Infusion Pumps, Needleless Connectors, IV Sets) 4U.S. Market for Infusion Therapy Devices 2011 (Infusion Pumps, Needleless Connectors, IV Sets) 5U.S. Market for Infusion Therapy Devices 2011 (Infusion Pumps, Needleless Connectors, IV Sets) 6U.S. Market for Infusion Therapy Devices 2011 (Infusion Pumps, Needleless Connectors, IV Sets) 7Robertson Global Health Solutions Announces Progress Towards Commercial Venture with LifeSense 2Robertson Global Health Solutions Announces Progress Towards Commercial Venture with LifeSense 3Robertson Global Health Solutions Announces Progress Towards Commercial Venture with LifeSense 4
(Date:10/1/2014)... more than 80 per cent of bowel cancers could ... that medicines called ,JAK inhibitors, halted tumour growth in ... in more than 80 per cent of bowel cancers. ... clinical trials, for diseases including rheumatoid arthritis, psoriasis, blood ... second-most common cancer in Australia with nearly 17,000 people ...
(Date:10/1/2014)... 2014 Patients with increased inflammation, including those ... increased risk of depression. For example, a 6-month ... C virus infection causes depression in approximately 30% ... commonly known as fish oil, have a long ... of heart disease and reducing triglyceride levels. These ...
(Date:10/1/2014)... Marriagelifeinsurance.com has released a new blog post ... , Senior citizens can purchase a joint life ... ones. A joint policy is cheaper, but will only ... , Life insurance can be used to cover important ... purchased online, as the application process is simple and ...
(Date:10/1/2014)... October 01, 2014 First Warning Systems, ... circadian cellular changes throughout the body, announced the company ... better address the company’s breadth of upcoming product releases. ... cancer screening technology. , “Our initial focus will be ... which detects abnormal circadian cellular changes over time,” said ...
(Date:10/1/2014)... Join the more than 80 golfers who already have ... charity golf tournament to benefit Project HEAL, a not-for-profit organization ... afford treatment. The tournament will be held Monday, Oct. 6, ... The day-long event starts with 10:30 a.m. check-in and shotgun ... begin at 5 p.m. and will include an auction featuring ...
Breaking Medicine News(10 mins):Health News:Eighty percent of bowel cancers halted with existing medicines 2Health News:Omega-3 fatty acids may prevent some forms of depression 2Health News:Elderly Life Insurance - Find Life Insurance for Retired Couples! 2Health News:First Warning Systems Changes Name to Cyrcadia Health to Better Reflect Core Competency and Goals of Company 2Health News:First Warning Systems Changes Name to Cyrcadia Health to Better Reflect Core Competency and Goals of Company 3Health News:First Warning Systems Changes Name to Cyrcadia Health to Better Reflect Core Competency and Goals of Company 4Health News:Project HEAL Benefit Golf Tournament Gaining Momentum 2Health News:Project HEAL Benefit Golf Tournament Gaining Momentum 3
... 6 The Foundation,for Taxpayer and Consumer Rights (FTCR) ... too much on what hospitals will pay in,fees for ... will cost,consumers., Yesterday, FTCR sent a letter to ... will be any limits placed on how much,individuals and ...
... presentation, BERKELEY HEIGHTS, N.J., Sept. 6 ... provider of software and,web-based services that enable enterprises ... business transactions, today,announced that it plans to report ... ended June 30, 2007 on Thursday, September 13, ...
... Mich., Sept. 6, 2007 Plexus Systems,Inc., providers ... today announced it has been named to the ... America. Plexus Systems, Inc. is ranked,at number 1581 ... http://www.newscom.com/cgi-bin/prnh/20070627/CLW071LOGO ) This is the ...
... Inc. (Nasdaq: IDIX ) announced today that management ... 20th Annual,Healthcare Conference on Tuesday, September 11th at 2:00 ... Conference on Thursday, September 20th at,3:30 p.m. (EDT), both ... The live and archived webcasts of the presentations can ...
... Par,Pharmaceutical Companies, Inc. (NYSE: PRX ) today filed ... Report on Form 10-K. The,filing of Par,s Form 10-K ... in restating its consolidated financial statements for certain,prior periods, ... file its,Form 10-Q for the first and second quarters ...
... Efforts to make open-heart,surgery a minimally invasive ... Institutes of Health Bioengineering Research Partnership award.,Professor ... Engineering,cardiac surgeon Pedro del Nido, M.D., at ... Microfabrica Inc. (Van Nuys,CA) will collaborate to ...
Cached Medicine News:Health News:Authentidate Holding Corp. to Report Fourth Quarter and Fiscal 2007 Year End Results on Thursday, September 13, 2007 2Health News:Authentidate Holding Corp. to Report Fourth Quarter and Fiscal 2007 Year End Results on Thursday, September 13, 2007 3Health News:Plexus Systems Ranks in Top Third of the 2007 Inc. 5,000 with Three-Year Sales Growth of 226% 2Health News:Plexus Systems Ranks in Top Third of the 2007 Inc. 5,000 with Three-Year Sales Growth of 226% 3Health News:Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts' Meeting September 28, 2007 2Health News:Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts' Meeting September 28, 2007 3Health News:Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts' Meeting September 28, 2007 4Health News:Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts' Meeting September 28, 2007 5Health News:Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts' Meeting September 28, 2007 6Health News:Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts' Meeting September 28, 2007 7Health News:Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts' Meeting September 28, 2007 8Health News:Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts' Meeting September 28, 2007 9Health News:Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts' Meeting September 28, 2007 10Health News:Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts' Meeting September 28, 2007 11Health News:Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts' Meeting September 28, 2007 12Health News:Minimally Invasive Heart Surgery Research Wins N.I.H. Award 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: